Baxalta Ventures

Baxalta Ventures

Baxalta Ventures

Learn about Baxaltas values, company leadership, and our passion for improving patient care.
Follow us
Alexa global traffic share
Latest investments Show all
$50,000,000
Venture capital (Series B)
Syntimmune
$8,000,000
Venture capital (Series A)
Syntimmune
Team Size
1–10
Employees
Past year's investments

Baxalta Ventures participated in fewer than 3 rounds over the past year

Latest rounds
  • Syntimmune: Venture capital (Series B) ($50M)
  • Syntimmune: Venture capital (Series A) ($8M)
  • OncoResponse: Undisclosed funding (Undisclosed amount)